Search results

595 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
CAR-T immunotherapy for lymphoma studied at UNC Lineberger receives fast-track designation from FDA
Based on proof-of-concept results from clinical trials at UNC Lineberger Comprehensive Cancer Center and Baylor College of Medicine, an investigational cellular immunotherapy for Hodgkin lymphoma has received a Regenerative Medicine Advanced Therapy designation from the U.S. Food and Drug Administration.
Located in News / 2020 / March
UNC Lineberger discovery would allow researchers to fine-tune activity of cancer-hunting immune cells
Researchers led by UNC Lineberger’s Gianpietro Dotti, MD, reported new findings about the regulation of co-stimulatory molecules that could be used to activate cancer-killing immune cells – chimeric antigen receptor T-cells, or CAR-T. The molecules could also be used to decrease the activity of these cells.
Located in News / 2020 / January
UNC Lineberger Research Provides New Insights Into Deadly Brain Cancer
New findings by researchers at UNC Lineberger Comprehensive Cancer Center suggest that the most common form of malignant brain cancer in adults, glioblastoma multiforme (GBM), is probably not a single disease but a set of diseases, each with a distinct underlying molecular disease process.
Located in Vital Signs / Archives / Vital Signs - Jan. 21, 2010
AACR Names Perou 2009 Outstanding Investigator for Breast Cancer Research
Calling his work “one of the most important findings in breast cancer and health disparities in the last decade,” the American Association for Cancer Research (AACR) has named Charles M. Perou, PhD the 2009 Outstanding Investigator Award for Breast Cancer Research, funded by Susan G. Komen for the Cure®.
Located in Vital Signs / 2009 / Vital Signs - Dec. 10, 2009
UNC Cancer Care TV commercials hit the air
We are excited to announce that new UNC Cancer Care TV commercials are ready to hit the air. Beginning Monday, Aug. 15, numerous networks and programs in the central North Carolina region will begin airing the new spots.
Located in Employee News Online / 2011 / Aug. 10
Clinical trial promotes new standards for colorectal cancer treatment
In a review article published this month in The Oncologist, UNC’s Dr. Richard M. Goldberg and a team of colleagues catalogue how the data collected in a single large comparative clinical trial testing combination chemotherapy for metastatic colorectal cancer has been used not only to benefit the patients that enrolled but also patients who subsequently developed the disease.
Located in Vital Signs / Archives / Vital Signs - Nov. 5, 2009
Consortium offers Colorectal Cancer Evidence Academy - March 12, 2010
The Western North Carolina Colorectal Cancer Evidence Academy: “From Prevention to Treatment” is being offered on March 12, 2010 at Lake Junaluska. CME and CEU credits will be offered.
Located in Vital Signs / Archives / Vital Signs - Jan. 4, 2010
Turn the Towns Pink to Support Cancer Patients and Families
Businesses in and around Chapel Hill and Carrboro will help Turn the Towns Pink in October as they partner with UNC Lineberger Comprehensive Cancer Center for a month-long promotion to raise funds for the Comprehensive Cancer Support Program (CCSP) at the new N.C. Cancer Hospital. The observance kicks off on Friday, October 2 at the Carolina Inn’s “Fridays on the Front Porch.”
Located in Vital Signs / Archives / Vital Signs - October 2, 2009
UNC study rewrites textbook on key genetic phenomenon
Because females carry two copies of the X chromosome to males’ one X and one Y, they harbor a potentially toxic double dose of the more than 1000 genes that reside on the X chromosome.
Located in Vital Signs / 2009 / Vital Signs - July 2, 2009
Chung appointed to the NIH Precision Medicine Initiative Cohort Research Program Institutional Review Board
Arlene Chung, MD, MHA, MMCi, will serve as an inaugural member of the NIH Precision Medicine Initiative Cohort Program Institutional Review Board.
Located in Vital Signs / 2016 / Sept. 8